Foreign device manufacturers must designate one U.S. agent through FDA’s Unified Registration and Listing System as part of annual establishment registration under 21 CFR Part 807. This agent serves as FDA’s official point of contact, receiving communications and, when designated, listing information on the manufacturer’s behalf. We guide foreign establishments through this designation and full registration compliance.
Key Takeaways
- Foreign device manufacturers must appoint a U.S. agent to represent their establishment for FDA compliance purposes.
- All foreign establishments submit U.S. agent information electronically through the FDA Unified Registration and Listing System (FURLS).
- Foreign device manufacturers engaged in production for U.S. commercial distribution register annually with the FDA without exception.
- Registered establishments list devices and activities alongside their U.S. agent designation in the FDA registration system.
What Is An FDA Registration Agent Exactly?
A FDA registration agent serves as the mandated U.S. representative for a foreign device manufacturer selling into the American market. This individual or entity must reside in the United States or maintain a place of business there. FDA will not process a foreign establishment’s registration without one identified on file.
We view this appointment as far more than a paperwork formality. It functions as the compliance bridge between a manufacturer overseas and the regulatory system governing every product entering U.S. commerce. Skip this step, and registration stalls before it starts.
Why does the FDA require a U.S. agent for foreign establishments?
Foreign establishments engaged in manufacturing, preparing, propagating, compounding, or processing a device destined for U.S. import must identify this representative first. The requirement exists because FDA needs a domestic point of contact reachable for inspections, communications, and enforcement matters. Without a properly designated agent, registration simply does not move forward.
What does the role actually involve day to day?
The agent’s responsibilities extend well beyond serving as a mailing address. Duties typically include:
- Receiving communications from FDA on behalf of the foreign manufacturer
- Assisting with navigation of registration requirements under U.S. law
- Serving as a liaison during inspections or agency inquiries
- Supporting timely responses to regulatory correspondence
Katherine Giannamore has practiced FDA and food-drug law for years, working directly with manufacturers navigating these registration obligations. Shehadeh Giannamore, PLLC provides registration and listing services as part of a broader regulatory practice, giving foreign manufacturers a resource for questions surrounding agent appointment and ongoing compliance. Getting this designation right at the outset prevents costly delays later.
Which Foreign Manufacturers Must Appoint One?
Registration obligations reach any establishment abroad that produces or distributes medical devices bound for U.S. commercial distribution. Devices manufactured overseas purely for export still trigger the annual registration requirement. Losing sight of this rule creates real exposure — unregistered establishments risk import refusals, product detentions, and enforcement action that halts market entry entirely.
Foreign manufacturers rarely operate in isolation from FDA’s broader regulatory framework. Our practice at Shehadeh Giannamore, PLLC covers food, beverage, dietary supplement, cosmetic, medical device, and OTC drug companies working toward FDA compliance both domestically and abroad. That breadth matters because many manufacturers produce devices alongside cosmetics or supplements. Each category carries its own registration and listing obligations under Title 21 of the Code of Federal Regulations.
Does registration apply to devices made only for export?
Yes. An establishment manufacturing devices exclusively for markets outside the United States still falls under the annual registration requirement once those devices are produced there. Location of manufacture, not final destination alone, determines the obligation.
What should manufacturers check before filing?
Before submitting registration paperwork, we recommend reviewing product labeling and marketing materials for compliance gaps. Our firm reviews products and marketing materials across foods, dietary supplements, cosmetics, and OTC drugs so companies can correct issues before registration rather than after an FDA inspection flags them.
Manufacturers preparing to register — whether appointing a FDA registration agent for the first time or renewing an existing designation — benefit from counsel familiar with these overlapping requirements. We encourage foreign manufacturers approaching this process to reach out for guidance on structuring compliant registration and listing submissions.
What Are The Agent’s Legal Responsibilities?
Legal responsibility begins with a single designation: each foreign establishment may name only one FDA registration agent, and that agent may also serve as the manufacturer’s official correspondent. Skipping this step, or naming more than one representative, invites confusion at exactly the moment the FDA expects clarity. We treat this appointment as a foundational compliance decision, not an afterthought.
Confirmation matters just as much as designation. The individual or entity named as agent must complete an automated verification step confirming agreement to act on the foreign manufacturer’s behalf. Without that confirmation, the registration record remains incomplete, and incomplete records draw scrutiny.
Does the agent bear liability for the manufacturer’s violations?
Liability questions arise often, and we address them directly with clients. Regulatory issues, such as import alert placements and warning letter responses, frequently trace back to poorly managed agent relationships. Our practice, led by Attorney Katherine Giannamore, handles these matters regularly, including:
- Ingredient and label reviews tied to registration accuracy
- Removals from import alerts triggered by agent-related lapses
- Responses to FDA warning letters
- Reviews of marketing materials referencing U.S. registration status
What happens if a manufacturer never appoints an agent?
Registration cannot proceed without one. The FDA treats the appointment as a prerequisite, not a formality, and enforcement consequences follow quickly when manufacturers overlook it.
Foreign manufacturers preparing to appoint an agent benefit from counsel before problems surface. Our firm remains reachable by phone. Email for companies weighing their options and structuring compliant registration filings from the outset.
How Does The FURLS Registration Process Work?
Foreign establishments file U.S. Agent information electronically through the FDA Unified Registration and Listing System, known as FURLS, as part of the annual establishment registration submission. The filing links directly to the plant or facility record. Registration and agent designation happen together rather than as separate steps. Missing or inaccurate agent data in that filing creates gaps in FDA’s ability to reach a manufacturer during an inspection, recall, or import review.
We guide foreign manufacturers, quality directors, and compliance officers through each field of the FURLS submission before it goes live. Our regulatory work covers 19 distinct FDA legal service areas. Registration and listing support sits at the core of that practice. We’ve represented clients on registration matters across the country and internationally. We recognize the filing errors that trigger FDA follow-up requests.
What information does FURLS require from a foreign manufacturer?
FURLS collects facility details, product listing data, and the designated FDA registration agent’s contact information in one electronic record. Each data point feeds into FDA’s compliance and enforcement systems. Accuracy at the time of filing matters more than speed.
Can our firm help complete a FURLS filing before the deadline?
Yes. We work through FURLS submissions with clients before deadlines arrive, checking agent designation and facility data against FDA’s current requirements.
Clients reach us seven days a week by phone or by email, and we typically respond within 24 hours. That turnaround matters when a FURLS filing window is closing. A manufacturer needs a compliance officer to confirm the record before submission.
What Changes Are Coming For Foreign Manufacturers?
New rulemaking targets a long-standing gap in FDA oversight of foreign tobacco producers. On June 29, 2026, FDA published a proposed rule titled “Establishment Registration and Product Listing for Tobacco Products.” The proposal would, for the first time, require foreign tobacco product manufacturers to register their establishments and list their products with the agency.
Domestic tobacco manufacturers have carried these registration and listing obligations for years. Foreign manufacturers, by contrast, currently face no such requirement. This proposal closes that gap, placing foreign and domestic producers under the same regulatory framework.
Why does this matter for compliance officers outside the U.S.?
Regulatory affairs teams at foreign facilities should treat this proposal as an early warning, not a distant abstraction. Once finalized, the rule would extend obligations that already govern domestic device and drug establishments to tobacco manufacturers overseas. Quality control directors who oversee export operations to the U.S. market benefit from tracking this rulemaking now, before compliance deadlines arrive.
What role does an FDA registration agent play in this shift?
An FDA registration agent typically serves as the U.S.-based point of contact required for foreign establishments under existing FDA programs. If the tobacco proposal finalizes as written, affected manufacturers will likely need similar representation to satisfy new listing duties.
We continue to provide registration and listing services for clients across multiple FDA-regulated industries. Our attorneys track emerging rulemaking like this proposal closely, so foreign manufacturers understand how shifting agent obligations affect their U.S. market access. Foreign tobacco manufacturers weighing next steps can reach out directly for guidance on securing proper FDA regulatory counsel before the rule takes final form.
FAQ
Who must serve as a foreign manufacturer’s U.S. agent?
The agent must be an individual or entity that resides in the United States or maintains a place of business there. ### Do manufacturers producing devices only for export still need to register?
Yes. Devices manufactured overseas purely for export still trigger the annual registration requirement under 21 CFR Part 807.
What happens if a foreign establishment skips registration?
Unregistered establishments risk import refusals, product detentions, and enforcement action that halts market entry entirely. Registration simply does not move forward without a properly designated U.S. agent.
Conclusion
In closing, foreign manufacturers navigating FDA registration requirements must designate a U.S. agent to serve as their regulatory liaison and point of contact with the agency. This requirement ensures compliance with federal law and facilitates seamless communication regarding product submissions, inspections, and enforcement matters. Engaging qualified regulatory counsel experienced in FDA registration protocols strengthens a manufacturer’s compliance posture. Mitigates potential enforcement risks in the American market.